Feymer(SH:688350)2021-04-28 16:00Financial Performance - Operating revenue rose by 36.76% to CNY 313,304,737.60 year-on-year[5] - Net profit attributable to shareholders increased by 30.23% to CNY 34,265,986.23 compared to the same period last year[5] - Basic and diluted earnings per share increased by 6.90% to CNY 0.31[5] - The company's revenue for Q1 2021 reached RMB 313,304,737.60, representing a 36.76% increase compared to RMB 229,084,196.31 in the same period last year[14] - The net profit for Q1 2021 was RMB 34,264,351.60, a 30.27% increase from RMB 26,301,791.30 year-on-year, driven by revenue growth[15] - Total operating revenue for Q1 2021 reached CNY 313,304,737.60, a 37% increase from CNY 229,084,196.31 in Q1 2020[28] - Net profit for Q1 2021 was CNY 34,264,351.60, representing a 30% increase compared to CNY 26,301,791.30 in Q1 2020[29] Assets and Liabilities - Total assets increased by 32.82% to CNY 1,740,357,780.68 compared to the end of the previous year[5] - The company's total assets as of Q1 2021 amounted to CNY 1,682,515,215.61, compared to CNY 1,255,900,361.19 in the previous year[26] - The company's equity attributable to shareholders increased to ¥1,371,379,399.39 from ¥970,190,247.08, reflecting a growth of 41.38%[22] - Total liabilities for Q1 2021 were CNY 314,283,843.37, an increase from CNY 285,923,503.49 in Q1 2020[26] Cash Flow - Cash flow from operating activities decreased by 91.04% to CNY 3,533,621.11 compared to the previous year[5] - The net cash flow from operating activities decreased by 91.04% to ¥3,533,621.11 compared to ¥39,435,406.25 in the same period last year, primarily due to increased tax expenses and employee compensation[16] - The net cash flow from investing activities was -¥258,784,789.42, a significant increase in outflow compared to -¥61,310,166.99 in the previous year, mainly due to an increase in structured deposits[16] - The net cash flow from financing activities improved to ¥386,598,073.65 from -¥731,161.40, attributed to funds raised from the initial public offering[16] Research and Development - R&D expenses accounted for 4.19% of operating revenue, an increase of 0.06 percentage points[6] - Research and development expenses for Q1 2021 were RMB 13,112,243.46, up 38.55% from RMB 9,463,948.43, indicating a return to normal project timelines after pandemic-related delays[14] - Research and development expenses increased to ¥8,413,932.73 in Q1 2021, a 81.5% rise from ¥4,638,001.86 in Q1 2020[30] Shareholder Information - The total number of shareholders reached 8,630 at the end of the reporting period[9] - The largest shareholder, Jiangsu Feixiang Chemical Co., Ltd., holds 48.66% of the shares[10] Other Financial Metrics - The weighted average return on equity decreased by 0.08 percentage points to 2.78%[5] - The company reported non-recurring gains of CNY 7,144,467.98 during the period[8] - Other income surged by 13626.89% to RMB 5,697,263.91, mainly from increased government subsidies unrelated to regular business activities[15] - The company's operating costs increased by 41.99% to RMB 242,886,115.59, primarily due to rising raw material prices[14] - The company reported a gross profit of CNY 33,373,527.90 for Q1 2021, compared to a gross loss of CNY 31,231,162.22 in Q1 2020[28]